Molecular Templates, Inc. logo

Molecular Templates, Inc.

NASDAQ:MTEM

Overview | Financials
Company Name Molecular Templates, Inc.
Symbol MTEM
Currency USD
Price 1.34
Market Cap 8,822,399
Dividend Yield 0%
52-week-range 1 - 7.15
Industry Biotechnology
Sector Healthcare
CEO Dr. Eric E. Poma Ph.D.
Website https://www.mtem.com

An error occurred while fetching data.

About Molecular Templates, Inc.

Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform. The company is developing MT-5111, an

Related Stocks

Black Diamond Therapeutics, Inc. logo

Black Diamond Therapeutics, Inc.

BDTX

4.73 USD

MEI Pharma, Inc. logo

MEI Pharma, Inc.

MEIP

3.04 USD

Pro-Dex, Inc. logo

Pro-Dex, Inc.

PDEX

25.5 USD

Hepion Pharmaceuticals, Inc. logo

Hepion Pharmaceuticals, Inc.

HEPA

0.675 USD

Medicenna Therapeutics Corp. logo

Medicenna Therapeutics Corp.

MDNA

0.157 USD

Biotricity, Inc. logo

Biotricity, Inc.

BTCY

0.32 USD

Purple Biotech Ltd. logo

Purple Biotech Ltd.

PPBT

7.1 USD

Solid Biosciences Inc. logo

Solid Biosciences Inc.

SLDB

7.14 USD

Financials

Numbers are in millions USD

Numbers are in millions USD